Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
about
An early peak of relapse after surgery for breast cancerFrom sprouting angiogenesis to erythrocytes generation by cancer stem cells: evolving concepts in tumor microcirculationCompensatory angiogenesis and tumor refractorinessEscaping Antiangiogenic Therapy: Strategies Employed by Cancer CellsMechanisms involved in breast cancer liver metastasisTargeting the vascular endothelial growth factor pathway in the treatment of human malignancy.Metastasis: a therapeutic target for cancer.Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseAnti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies.The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?Therapeutic targets for antimetastatic therapy.Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumorsRedirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver MetastasesAntiangiogenic therapy in human gastrointestinal malignancies.Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancerFirst international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancerPrognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer.Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesionsVessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea.Prostate tumor cell plasticity: a consequence of the microenvironment.Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.The morphological growth patterns of colorectal liver metastases are prognostic for overall survival.Targeting metastasis.Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.Tumor angiogenesis revisited: Regulators and clinical implications.Growth pattern of colorectal liver metastasis as a marker of recurrence risk.Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastasesEvidence Showing That Tumors Can Grow Without Angiogenesis and Can Switch Between Angiogenic and Nonangiogenic Phenotypes.Lack of lymphangiogenesis during breast carcinogenesis.Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?The histological growth pattern of colorectal cancer liver metastases has prognostic value.Hostile takeover: how tumours hijack pre-existing vascular environments to thrive.International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.
P2860
Q24796254-77097E62-B55E-483B-94A5-F54EDA0F7B9AQ26827148-36BBF614-75DB-4B9E-A2B0-691F396D726CQ26851916-3BC029AF-1C97-46CB-8D04-8129BBF9B618Q28067753-684C60F2-3B3B-4A9B-AAF1-2346CE5155F7Q28084024-67DF883F-07D8-4698-87D6-BE7CBB97918EQ30358961-F97A0BD9-882F-47FB-A2A8-13D29640FFB2Q30439221-F1899898-4909-45C6-A003-60C6FD45109DQ30573416-6F8EA6E2-BF3A-47D9-9AFF-A819F38B7F35Q33770680-7B9FA7CF-90E8-4962-81B4-F545324E988BQ34088774-DF40DF06-E8B8-4FA4-BE21-59B0C095B159Q35221807-CB7C24F4-8E9D-49D9-A87B-C2D3ECC3E29CQ35684577-06C2543D-1495-4296-8BFD-1136C54DD1F8Q35976350-796F78CD-C81C-4C96-A6D9-34EA3999D8EBQ36296805-A8F234CC-0EB9-4F60-A60A-168D33BAF633Q36471409-3DD0B918-6A42-4DBF-A1A1-35918B58FA24Q36591067-785122F4-D529-4D3A-B10A-0E7A1829336CQ36611984-AAB5679F-22F6-47AB-96BF-BCCA2A0C2188Q36612618-1D6F12AB-737B-436A-8F18-5E280296B6F5Q36614929-FB6C2032-BFEB-46E8-BC5C-9ECE10154DB1Q36695762-E9F9F6AD-5330-4B8F-BEB0-BBF546CB78B7Q37033738-EAB3D7E9-D6DC-4E74-8897-8CE1ACFC614DQ37236229-50AC20CC-E62F-4303-B3A3-AF437C62A606Q37346912-B050AAE4-7651-4872-A253-207E5E9E9A37Q37407384-5CD8AD17-F254-4070-8235-F5D1366A8BD5Q37595980-F7CA973A-FFAC-4072-B027-D4D8E008E67CQ37688491-41E0B926-89A1-4A76-902D-F054DAD59B93Q37929041-41DFC9FA-A07D-4C46-A946-7CC2B0528923Q38021354-0558C805-1C01-4FCF-92A5-3F609BCBEF8EQ38391622-A4E11997-0163-4D20-817A-EF6D41D6039AQ38786658-B3B1A483-9F98-4A76-8A19-0F2B35E70BFDQ38919372-21B31C6D-BA3F-4CF0-BA04-962E99961FB5Q39393740-37FD2D61-558E-49DA-89BF-B046A140B25FQ41140410-1EA237C9-671E-4D3B-A0A8-F67A6E934F89Q42003363-4EFA6335-CEF4-4762-9CAA-352F135E379AQ42396415-F10EC861-4B4E-4104-A685-7868E79DE294Q43010451-3F46B792-9E60-4DEA-997E-D058CD00751EQ46082308-12CE50A0-00D1-4504-A8A4-9C081130A08BQ47942254-25F1A7CA-6635-4C23-8A1B-BCB913121B03Q48301861-13D93F26-078A-41A3-9EC4-D5A0BB347C28Q48579264-764F04F7-E2A8-4DA0-91AE-A5AE7329AC7C
P2860
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Breast adenocarcinoma liver me ...... the stroma and lacks hypoxia.
@en
type
label
Breast adenocarcinoma liver me ...... the stroma and lacks hypoxia.
@en
prefLabel
Breast adenocarcinoma liver me ...... the stroma and lacks hypoxia.
@en
P2093
P2860
P921
P356
P1476
Breast adenocarcinoma liver me ...... the stroma and lacks hypoxia.
@en
P2093
C G Colpaert
D G Jackson
E A van Marck
E Van den Heuvel
F Stessels
G Van den Eynden
I Van der Auwera
P B Vermeulen
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601727
P407
P577
2004-04-01T00:00:00Z
P5875
P6179
1026763151